▸ THE ONE-LINER

75 insider sells this week. One buy.

Vertex Pharmaceuticals entered a material definitive agreement, triggering multiple simultaneous disclosures across regulatory, event, and financial exhibit categories. The breadth of items filed together suggests a transaction or partnership rather than routine corporate housekeeping. VRTX is trading near its 52-week high at $529.59, meaning the market will scrutinize this agreement closely for whether it justifies the current valuation.

Analog Devices locked in a new credit facility, adding a direct financial obligation to its balance sheet at a time when the stock sits near the midpoint of its 52-week range. the semiconductor cycle is still finding its footing after a prolonged inventory correction. A fresh credit line gives ADI dry powder for acquisitions or capital returns, but it also adds leverage that investors will want to see deployed productively.

S&P Global closed the acquisition of Visible Alpha, a consensus data and analytics platform used widely by buy-side analysts. The deal adds granular financial model data to SPGI's Market Intelligence segment, filling a gap that competitors like Bloomberg and FactSet have long exploited. For investors, this is a small but strategically coherent bolt-on that deepens the data moat rather than a transformational bet.

SPREAD THE FILE

KNOW SOMEONE WHO
TRACKS THE INSIDERS?